About the Company
Beijing Shenzhen Zhiyao Technology Co., Ltd
Company Profile
AI-native platform for life sciences and material sciences, accelerating R&D from years to weeks. AI deeply understands biological...
Who We Are
Beijing Shenzhen Zhiyao Technology Co., Ltd

Company Introduction
AI-native platform for life sciences and material sciences, accelerating R&D from years to weeks. AI deeply understands biological mechanisms to design proactively, not passively. It interprets pathways and targets, and drives drug design backward from clinical needs. Completed Series D financing at a multi-billion dollar valuation, backed by top-tier global investors including HongShan, CDH Investments, ZhenFund, and CITIC Capital. DIP deeply integrates large-scale AI models with scientific computing, compressing the cycle from molecular screening to candidate confirmation from years to weeks. Expert + AI collaboration: experts provide domain judgement while AI Agents handle data processing and pattern recognition for measurable performance gains. "Connect protocol design to final CSR delivery with one continuous data flow,creating a seamless end-to-end pipeline for faster global launches." DIP's AI-driven pharmaceutical R&D model has been validated by leading global industry partners, achieving sustained profitability and growth. Driving full value-chain commercialization across AI life sciences, while strengthening core competitiveness through sustained R&D investment. Transfer AI capability from life-science complex systems to materials screening, from crystal prediction to surface-energy computation. Established Japan operations as a strategic gateway for global high-standard compliance and Asia-Pacific business expansion. Established by AI scientists from global pharma giants, DIP focuses on cutting-edge innovations in AI-driven life sciences. In collaboration with a leading new-energy company, high-throughput simulation replaced years of trial-and-error. Achieved human-AI collaboration in life sciences, pioneering the era of intelligent agents in pharmaceutical R&D. A biotech used AI-assisted protocol design to achieve 12x acceleration and submit IND ahead of competitors.
Get in Touch
Let’s build something together.
Contact Beijing Shenzhen Zhiyao Technology Co., Ltd to discuss your requirements.